drugset / Trial / NCT00628758
A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective is to compare the efficacy of Symbicort Single inhaler Therapy with treatment according to conventional best practice in adult patients with persistent asthma.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Symbicort | Unknown | 4.5 ug | Inhaled |
| Background | Symbicort | Unknown | 160 ug | Inhaled |
| Background | Astmerol | Unknown | — | — |
| Background | Bricanyl | Unknown | — | — |
| Background | Combivent® | Unknown | — | — |
| Background | Formoterol | Other / unclassified | — | — |
| Background | Salbulin | Unknown | — | — |
| Background | Salbutamol | Unknown | — | — |
| Background | Salbutamol Sustained Release | Unknown | — | — |
| Background | Salbutol | Unknown | — | — |
| Background | Seretide | Unknown | — | — |
| Background | Symbicort | Unknown | — | — |
| Background | Vent-o-sal | Unknown | — | — |
| Background | Ventofor | Unknown | — | — |
| Background | salmeterol xinafoate | Unknown | — | — |